UnitedHealth Group Incorporated $UNH Shares Bought by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,226 shares of the healthcare conglomerate’s stock after acquiring an additional 13,804 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $99,145,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. NTV Asset Management LLC grew its position in shares of UnitedHealth Group by 43.6% during the first quarter. NTV Asset Management LLC now owns 636 shares of the healthcare conglomerate’s stock worth $333,000 after buying an additional 193 shares in the last quarter. Stratos Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 25.3% in the first quarter. Stratos Wealth Advisors LLC now owns 3,114 shares of the healthcare conglomerate’s stock valued at $1,631,000 after purchasing an additional 629 shares in the last quarter. Finally, Trek Financial LLC boosted its holdings in UnitedHealth Group by 222.8% in the first quarter. Trek Financial LLC now owns 2,644 shares of the healthcare conglomerate’s stock valued at $1,385,000 after purchasing an additional 1,825 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. UBS Group upped their price target on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Royal Bank Of Canada upped their price target on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Finally, Truist Financial boosted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $327.68 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The business has a 50 day simple moving average of $345.17 and a 200-day simple moving average of $324.09. The stock has a market capitalization of $296.83 billion, a PE ratio of 17.10, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.